About this trial
Introduction:
The goal of this observational study is to learn whether point-of-care ultrasound (POCUS) can help detect early fluid build-up under the skin after open abdominal surgery (laparotomy) and whether these findings can predict surgical site infection. The study includes adults who recently had emergency or planned open abdominal surgery.
Hypothesis:
The main questions it aims to answer are:
1. Does ultrasound identify subcutaneous fluid collections early after surgery? 2. Do these fluid collections help predict which participants will develop a surgical site infection?
Intervention:
Participants will:
1. Have a superficial wound swab taken once at the start of the study (for research only). 2. Receive three ultrasound scans of their surgical wound during days 1-3, 4-6, and 7-9 after surgery. 3. Have their wound checked for redness, swelling, tenderness, or discharge before each scan. 4. Be followed for 7 and 30 days after surgery (and up to 90 days if they have implanted mesh) to see whether an infection develops.
Ultrasound is non-invasive and safe. According to the protocol, "no serious adverse effects are expected," though some participants may feel brief discomfort from pressure on a tender wound.
This study will help researchers understand whether routine bedside ultrasound can support earlier detection of wound infections and improve postoperative care in the future.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults >18 years.
Undergoing emergency or elective laparotomy.
Primary or delayed primary wound closure (DPC).
Wound classification: clean, clean-contaminated, contaminated, or dirty.
Disqualifiers
Laparoscopic surgery
Wounds healing by secondary intention.
Ongoing wound dehiscence treatment with Negative Pressure Wound Therapy (NPWT).
Non-Danish residents
Trial design
Single group
Treatments tested in this trial
Point-of-Care Ultrasound (POCUS)
Diagnostic testThree standardized postoperative ultrasound examinations performed on post-operative day 1-3, 4-6, and 7-9 to measure subcutaneous fluid collections and assess the risk of surgical site infection.
Microbiological Wound Swab
Diagnostic testSingle postoperative swab of the closed incision and surrounding skin obtained between POD 1-3 for microbiological assessment.
ASEPSIS Wound Assessment
Diagnostic testStructured wound scoring performed at each postoperative assessment to evaluate clinical signs of surgical site infection.
Standardized Wound Photography
Diagnostic testPhotographic documentation of the surgical incision at each postoperative assessment to support blinded evaluation.
Treatment groups
Trial outcomes
Primary outcomes
Incidence of surgical site infection (SSI) within 30 days stratified by presence of POCUS-detected subcutaneous fluid
SSI occurrence will be compared between participants with and without postoperative subcutaneous fluid collections detected on point-of-care ultrasound. SSI will be defined according to CDC criteria. Fluid presence and volume will be recorded during scheduled POCUS examinations.
Secondary outcomes
Diagnostic accuracy of combined POCUS and ASEPSIS scoring for detecting surgical site infection
Sensitivity, specificity, and predictive values of POCUS, ASEPSIS, and their combined use will be calculated for identifying SSI. Diagnostic performance will be compared using AUROC analysis.
Accuracy of electronic wound imaging for detecting surgical site infection
Standardized wound photographs will be evaluated to determine whether electronic imaging supports or improves detection of SSI when used alongside ASEPSIS scoring.
Microbiological profile of laparotomy wounds associated with surgical site infection
Microbiological swabs obtained between POD 1-3 will be analyzed to identify organisms associated with increased SSI risk.
Rate of 30-day readmissions related to surgical site infection
All-cause and SSI-related readmissions will be recorded, including cases where POCUS identified subclinical fluid collections not detected clinically.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Slagelse Hospital
Lead sponsor
Zealand University Hospital
Collaborator
Copenhagen University Hospital at Herlev
Collaborator